Amantadine does not have antiviral activity against Borna disease virus

Arch Virol. 1997;142(10):2035-42. doi: 10.1007/s007050050220.

Abstract

We have investigated the antiviral activity of amantadine (AD) against Borna disease virus (BDV) in several culture cell systems. We present evidence that AD, in the range 5 to 10 microM, does not have antiviral activity against BDV. Treatment of BDV infected cells with AD for six days caused neither a reduction in the number of infected cells, nor a decrease in steady state levels of BDV RNA or proteins. Moreover, treatment of cells with AD prior infection did not affect BDV multiplication, whereas influenza A virus yield was less than 1% with respect to that obtained in untreated control cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amantadine / analogs & derivatives
  • Amantadine / pharmacology*
  • Animals
  • Antigens, Viral / metabolism
  • Antiviral Agents / pharmacology*
  • Borna disease virus / drug effects*
  • Borna disease virus / genetics
  • Borna disease virus / metabolism
  • Cell Line
  • Dogs
  • RNA, Viral / metabolism
  • Rabbits
  • Rats
  • Tumor Cells, Cultured
  • Viral Proteins / metabolism

Substances

  • Antigens, Viral
  • Antiviral Agents
  • RNA, Viral
  • Viral Proteins
  • p40 protein, Borna disease virus
  • Amantadine